| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.cian.co | |
| Market Cap | 53.07 Cr. | |
| Enterprise Value(EV) | 93.35 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 0.81 | Trailing Twelve Months Ending 2023-03 |
| Price-Earning Ratio (PE) | 26.15 | Trailing Twelve Months Ending 2023-03 |
| Industry PE | 41.99 | Trailing Twelve Months Ending 2023-03 |
| Book Value / Share | 18.98 | Trailing Twelve Months Ending 2023-03 |
| Price to Book Value | 1.12 | Calculated using Price: 21.23 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 2.50 Cr. | 24,995,764 Shares |
| FaceValue | 10 | |
| About Cian Healthcare Ltd. | ||
| The Company develops, manufactures and commercializes pharmaceutical products including sales, marketing, quality assurance, distribution, compliance and regulatory aspects under 12 therapeutic segments like Orthopaedics, Gynaecology, Paediatrics, Cardiac, Diabetic, Dermatology, Pain Management, Antibiotics, Neuro, Critical Care, Gastro-Intestinal and Nutraceuticals, along with 10 sales division focused on developing and growing its engagements in specialist and super specialist division. The company works under different business models like Brand Business, Export, Third Party Manufacturing and Government Supplies. The Company manufactures innovative products comprising of Tablets, Capsules, Liquid Orals, Ointments, Creams, Lotions, Gels and Sachet. The Company has special licence for manufacturing veterinary products for client like SAVAvet and Venky's. | ||
| 1 Day |
|
+4.57% |
| 1 Week |
|
+3.69% |
| 1 Month |
|
+7.35% |
| 3 Month |
|
-4.97% |
| 6 Month |
|
+11.61% |
| 1 Year |
|
-33.43% |
| 2 Year |
|
+5.97% |
| 5 Year |
|
|
| 10 Year |
|
| 4 years | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | -7.53 | 0.1 | -10.51 | 4.06 | |
| Return on Capital Employed (%) | 3 | 6.99 | 0.46 | 7.41 | |
| Return on Assets (%) | -2.42 | 0.03 | -3.42 | 1.24 |
| Particulars | 5 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 58 | 58 | 55 | 57 | 56 | |
| Non Curr. Liab. | 50 | 41 | 41 | 38 | 37 | |
| Curr. Liab. | 48 | 58 | 69 | 65 | 71 | |
| Minority Int. | ||||||
| Equity & Liab. | 157 | 157 | 166 | 160 | 163 | |
| Non Curr. Assets | 94 | 88 | 84 | 76 | 84 | |
| Curr. Assets | 54 | 63 | 79 | 74 | 79 | |
| Misc. Exp. not W/O | 8 | 5 | 3 | 10 | ||
| Total Assets | 157 | 157 | 166 | 160 | 163 |
| Particulars | 4 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Net Sales | 57 | 74 | 78 | 69 | |
| Other Income | 1 | 0 | 1 | 1 | |
| Total Income | 58 | 74 | 78 | 69 | |
| Total Expenditure | -50 | -62 | -74 | -56 | |
| PBIDT | 8 | 12 | 5 | 14 | |
| Interest | -7 | -8 | -7 | -6 | |
| Depreciation | -4 | -3 | -4 | -5 | |
| Taxation | 0 | -1 | 0 | 0 | |
| Exceptional Items | 0 | 0 | 0 | 0 | |
| PAT | -4 | 0 | -6 | 2 | |
| Minority Interest | |||||
| Share Associate | |||||
| Other Related Items | |||||
| Consolidated Net Profit | -4 | 0 | -6 | 2 | |
| Adjusted EPS | -2 | 0 | -2 | 1 |
| Particulars | 4 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | -7 | 6 | 9 | 5 | |
| Cash Fr. Inv. | -27 | 3 | 1 | 3 | |
| Cash Fr. Finan. | 36 | -10 | -11 | -7 | |
| Net Change | 1 | -1 | -1 | 0 | |
| Cash & Cash Eqvt | 3 | 2 | 1 | 1 |
|
Fri, 12 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate under Regulation 74(5) of SEBI(DP) Regulations 2018 for the quarter ended on 31st March 2024 |
|
Sat, 06 Apr 2024
Quarterly Disclosures By Listed Entities Of Defaults On Payment Of Interest/ Repayment Of Principal Amount On Loans From Banks / Financial Institutions And Unlisted Debt Securities Quarterly Disclosures by listed entities of defaults on payment of interest/ repayment of principal amount on loans from banks / financial institutions and unlisted debt securities |
|
Sat, 30 Mar 2024
Closure of Trading Window Intimation for Trading window closure for the year ended on 31st March 2024 |
| Fri, 26 Apr 2024 |
Opening at High
|
Opening at High for 3 days
|
Opening at High for 2 Days
|
Making Lower Lows for 2 Days
|
High Decrease in 1 Year
|
